Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
A Randomized Factorial-Design Phase II Trial of Temozolomide in Combination with possible Permutations of Thalidomide Isotretinoin and/or Celecoxib as Post-Radiation Adjuvant of Glioblastoma Mutiforme
Houston Methodist
Project
:
Non Profit
Overview
Project Details
Status
Finished
Effective start/end date
1/6/10
→
1/5/12
Funding
Univ of Texas MD Anderson Cancer Center
View all
View less